Markets by TradingView
TRENDS IN THE COVID WAR

VACCINATED MORE LIKELY TO BECOME INFECTED WITH COVID VARIANTS, SAYS NEW STUDY

October 5, 2021October 5, 2021
0

A study of more than 1,300 San Francisco area residents shows those who received COVID vaccinations were more likely to be infected with COVID variants than unvaccinated individuals.
The study, while not yet peer reviewed, would provide more evidence that the vaccines are creating serious problems.
The blog Conservative Treehouse picked up on the study, noting:
“The California study finds that vaccinated individuals are more susceptible to COVID variant infections than unvaccinated.  Geer Vanden Bossche has been warning that vaccine antibodies would suppress natural antibody responses.  The vaccine antibodies take control of the immune system and defend only against a targeted virus.”
According to the study’s abstract summary:
“Here we analyzed SARS-CoV-2 whole-genome sequences and viral loads from 1,373 persons with COVID-19 from the San Francisco Bay Area from February 1 to June 30, 2021, of which 125 (9.1%) were vaccine breakthrough infections. Fully vaccinated were more likely than unvaccinated persons to be infected by variants carrying mutations associated with decreased antibody neutralization (L452R, L452Q, E484K, and/or F490S) (78% versus 48%, p = 1.96e-08), but not by those associated with increased infectivity (L452R and/or N501Y) (85% versus 77%, p = 0.092). Differences in viral loads were non-significant between unvaccinated and fully vaccinated persons overall (p = 0.99) and according to lineage (p = 0.09 – 0.78). Viral loads were significantly higher in symptomatic as compared to asymptomatic vaccine breakthrough cases (p < 0.0001), and symptomatic vaccine breakthrough infections had similar viral loads to unvaccinated infections (p = 0.64).” 
The study was posted recently on the medRxiv.org website.  
Among the study’s dozens of researchers are:

  • Katherine T. Hernandez, San Francisco Department of Public Health
  • Venice Servellita, of the Department of Laboratory Medicine, University of California San Francisco
  • Erika Torres, Color Genomics, Inc., San Francisco
  • Mary-Kate Morris of Viral and Rickettsial Disease Laboratory, California Department of Public Health

MedRxiv serves as an online archive and distribution server for complete but unpublished manuscripts (preprints) in the medical, clinical, and related health sciences. 
MedRxiv cautions that posted studies are not yet peer reviewed, and should not be reported in news media as established information.

Comments are closed.

Skip to content